HCMV Vaccine Development Targets Immunomodulatory Proteins - MDPI Magazine Highlight, April 17, 2014 03:23

Human cytomegalovirus (HCMV) can cause severe disease in immunocompromised individuals and in congenitally infected infants, thus the development of an HCMV vaccine has been a national priority over the last few decades. Despite attempts similar to those which have proven successful for other herpesviruses, such as varicella zoster virus, attenuated HCMV vaccine strains (such as Towne) have not been analogously successful as effective HCMV vaccines. Continue reading →

Australian Bat Lyssavirus Tropism and Viral Entry: Viruses Review Paper recommended by F1000, April 7, 2014 06:04

A 2014 review article, “Recent Observations on Australian Bat Lyssavirus Tropism and Viral Entry“, has been recommended and rated by F1000. Broder et al. provide a summary of a recently emerged rhabdovirus considered endemic in Australian bat populations and furthermore, discuss the early pathogenesis of infection.

The article recommendation can be accessed via the F1000 website

Viruses - Official Sponsor of the EMBO Conference: Viruses of Microbes, Zurich, Switzerland, 14-18 July 2014, March 31, 2014 12:14

Viruses is an official sponsor of the EMBO conference Viruses of Microbes: Structure and Function, from Molecules to Communities, Zurich, Switzerland, 14-18 July 2014. We would be pleased to welcome you at our exhibition booth.

EMBO conference - Viruses of Microbes: Structure and Function, from Molecules to Communities, Zurich, Switzerland, 14-18 July 2014

Monoclonal Antibody to HCMV Glycoprotein B - MDPI Magazine Highlight, March 24, 2014 05:52

Guest Post by Anamaris Colberg-Poley*

Human cytomegalovirus (HCMV) is the major cause of congenital birth infections in developed countries. HCMV can cause severe birth defects including microcephaly, mental retardation, sensorineural hearing loss, and intrauterine growth restriction. However, because of the potential for teratogenicity and toxic effects, no therapeutic treatment is currently approved by the Food and Drug Administration for congenital HCMV infection. The studies by Lenore Pereira and her colleagues (Zydek et al., 2014. Viruses Special Issue on Recent CMV Research) have significant implications for developing therapies for treatment of congenital HCMV infections, which are seriously lacking at this time. Continue reading →

 

Special Issue "Recent Progress in Bacteriophage Research" - Now Available in Book Format, January 21, 2014 06:58

The Viruses special issue "Recent Progress in Bacteriophage Research", guest edited by Graham F. Hatfull is now available in book format. The book contains all 14 papers available on the special issue website.

To order your copy, please contact the editorial staff at books@mdpi.com. One copy, hardcover, 356 pages, 170x240mm premium format, full color is CHF24 + shipping from Switzerland (Economy: CHF30/Europe; CHF38/International or Priority: CHF38/Europe; CHF50/ International).

Special Issue "Pneumoviruses and Metapneumoviruses" - Now Available in Book Format, January 21, 2014 06:53

The Viruses special issue "Pneumoviruses and Metapneumoviruses", guest edited by Helene F. Rosenberg and Joseph B. Domachowske is now available in book format. The book contains all 17 papers available on the special issue website.

To order your copy, please contact the editorial staff at books@mdpi.com. One copy, hardcover, 328 pages, 170x240mm premium format, full color is CHF36 + shipping from Switzerland (Economy: CHF30/Europe; CHF38/International or Priority: CHF38/Europe; CHF50/ International).